Anti-inflammatory and analgesic effects and molecular mechanisms of JCICM-6, a purified extract derived from an anti-arthritic Chinese herbal formula

Phytomedicine

Volumn 15, Issue 6-7, 2008, Pages 416-426

  Wong, Y F ^a   Zhou, H ^a   Wang, J R ^a   Xie, Y ^a   Xu, H X ^b   Liu, L ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti inflammation; Anti nociception; COX; Cytokines; Herbal formula; iNOS; JCICM 6

Indexed keywords

CARRAGEENAN; CHINESE DRUG; CURCUMA LONGA EXTRACT; CYCLOOXYGENASE 2; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; JCICM 6; PAEONIA RADIX;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; CURCUMA LONGA; DRUG DOSE COMPARISON; DRUG MEGADOSE; HYPERALGESIA; LOW DRUG DOSE; NONHUMAN; PAEONIA SUFFRUTICOSA; PAW EDEMA; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINES; DRUGS, CHINESE HERBAL; EDEMA; EXUDATES AND TRANSUDATES; HYPERALGESIA; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; RATS; RATS, WISTAR;

RATTUS;

EID: 44949096301     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.02.008     Document Type: Article

References (42)

1. Appleby S.B., Ristimaki A., Neilson K., Narko K., and Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem. J. 302 Pt 3 (1994) 723-727
2. Bischof R.J., Zafiropoulos D., Hamilton J.A., and Campbell I.K. Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin. Exp. Immunol. 119 (2000) 361-367
3. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2 (2001) 907-916
4. Cai X., Zhou H., Wong Y.F., Xie Y., Liu Z.Q., Jiang Z.H., Bian Z.X., Xu H.X., and Liu L. Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis. Biochem. Biophys. Res. Commun. 337 (2005) 586-594
5. Cai X., Zhou H., Wong Y.F., Xie Y., Liu Z.Q., Jiang Z.H., Bian Z.X., Xu H.X., and Liu L. Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula. J. Ethnopharmacol. 10 1 (2006) 39-48
6. Calatayud S., Warner T.D., Breese E.J., and Mitchell J.A. Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: role of cyclo-oxygenase inhibitors. Br. J. Pharmacol. 134 (2001) 1237-1244
7. Campbell I.K., Rich M.J., Bischof R.J., Dunn A.R., Grail D., and Hamilton J.A. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161 (1998) 3639-3644
8. Cassatella M.A., Meda L., Bonora S., Ceska M., and Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178 (1993) 2207-2211
9. Chen J.K., and Chen T.T. Chinese Medical Herbology and Pharmacology (2001), Art of Medicine Press, California
10. Chou T.C. Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia. Br. J. Pharmacol. 139 (2003) 1146-1152
11. Cook A.D., Braine E.L., Campbell I.K., Rich M.J., and Hamilton J.A. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 3 (2001) 293-298
12. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107 (1992) 660-664
13. Cunha F.Q., Poole S., Lorenzetti B.B., Veiga F.H., and Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br. J. Pharmacol. 126 (1999) 45-50
14. Dannenberg A.J., Altorki N.K., Boyle J.O., Dang C., Howe L.R., Weksler B.B., and Subbaramaiah K. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol. 2 (2001) 544-551
15. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503-508
16. Fenton M.J., Buras J.A., and Donnelly R.P. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 149 (1992) 1283-1288
17. Fiorentino D.F., Bond M.W., and Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170 (1989) 2081-2095
18. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
19. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23 (2002) 144-150
20. Jenkins J.K., Malyak M., and Arend W.P. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13 (1994) 47-54
21. Kroncke K.D., Fehsel K., and Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113 (1998) 147-156
22. Liu L., Resch K., and Kaever V. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int. J. Immunopharmacol. 16 (1994) 685-691
23. Liu L., Buchner E., Beitze D., Schmidt-Weber C.B., Kaever V., Emmrich F., and Kinne R.W. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int. J. Immunopharmacol. 18 (1996) 529-543
24. Orino E., Sone S., Nii A., and Ogura T. IL-4 up-regulates IL-1 receptor antagonist gene expression and its production in human blood monocytes. J. Immunol. 149 (1992) 925-931
25. Rafatullah S., Tariq M., Al-Yahya M.A., Mossa J.S., and Ageel A.M. Evaluation of turmeric (Curcuma longa) for gastric and duodenal antiulcer activity in rats. J. Ethnopharmacol. 29 (1990) 25-34
26. Rothwell N.J. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol. Sci. 12 (1991) 430-436
27. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90 (1993) 7240-7244
28. Salvemini D., Wang Z.Q., Wyatt P.S., Bourdon D.M., Marino M.H., Manning P.T., and Currie M.G. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 118 (1996) 829-838
29. Schindler R., Ghezzi P., and Dinarello C.A. IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 144 (1990) 2216-2222
30. Silverstein F.E., Faich G., Goldstein J.L., Simon L.S., Pincus T., Whelton A., Makuch R., Eisen G., Agrawal N.M., Stenson W.F., Burr A.M., Zhao W.W., Kent J.D., Lefkowith J.B., Verburg K.M., and Geis G.S. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 284 (2000) 1247-1255
31. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., Talley J.J., Masferrer J.L., Seibert K., and Isakson P.C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA 95 (1998) 13313-13318
32. Smolen J.S., and Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat. Rev. Drug Discov. 2 (2003) 473-488
33. Süleyman H., and Büyükokuroǧlu M.E. The effects of newly synthesized pyrazole derivatives on formaldehyde-, carrageenan-, and dextran-induced acute paw edema in rats. Biol. Pharm. Bull. 24 (2001) 1133-1136
34. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., and Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481 (2001) 243-268
35. Suzuki Y., Oyama T., Ishige A., Isono T., Asami A., Ikeda Y., Noguchi M., and Omiya Y. Antinociceptive mechanism of the aconitine alkaloids mesaconitine and benzoylmesaconine. Planta Med. 60 (1994) 391-394
36. Tsai H.Y., Lin Y.T., Tsai C.H., and Chen Y.F. Effects of paeoniflorin on the formalin-induced nociceptive behaviour in mice. J. Ethnopharmacol. 75 (2001) 267-271
37. Vane J.R., and Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 47 Suppl 2 (1998) S78-S87
38. Verpoorte R. Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discov. Today 3 (1998) 232-238
39. Wahl S.M., Allen J.B., Ohura K., Chenoweth D.E., and Hand A.R. IFN-gamma inhibits inflammatory cell recruitment and the evolution of bacterial cell wall-induced arthritis. J. Immunol. 146 (1991) 95-100
40. Weyand C.M. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 39 Suppl. 1 (2000) 3-8
41. Winter C.A., Risley E.A., and Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc. Soc. Exp. Biol. Med. 111 (1962) 544-547
42. Zhou H., Wong Y.F., Cai X., Liu Z.Q., Jiang Z.H., Bian Z.X., Xu H.X., and Liu L. Suppressive effects of JCICM-6, the extract of an anti-arthritic herbal formula, on the experimental inflammatory and nociceptive models in rodents. Biol. Pharm. Bull. 29 (2006) 253-260 [Erratum in: Biol. Pharm. Bull. 2007, 30(12): 2412]